Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma

Journal of Neuro-Oncology

Volumn 111, Issue 1, 2013, Pages 19-23

  Petrecca, Kevin ^a   Guiot, Marie Christine ^a   Panet Raymond, Valerie ^b   Souhami, Luis ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Brain cancer; Failure; Glioblastoma; Gliomas; Gliomas surgery; Recurrence

Indexed keywords

BEVACIZUMAB; EVEROLIMUS; GADOLINIUM; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MICROSURGERY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; TREATMENT FAILURE;

EID: 84871799914     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0983-4     Document Type: Article

References (15)

1. Demuth T, Berens ME (2004) Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70:217-228
2. Chamberlain MC (2007) Radiographic patterns of relapse in glioblastoma. J Neurooncol 101:319-323
3. Dobelbower MC, Burnet OL III, Nordal RA, Nabors LB, Markert JM, Hyatt MD, Fiveash JB (2011) Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. J Med Imaging Radiat Oncol 55:77-81
4. McDonald MW, Shu HKS, Curran WJ Jr, Crocker IR (2011) Pattern of failure after limited radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys 79:130-136
5. Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, Lanzetta G, Scarpino S, Arcella R, Enrici RM (2010) Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 97:377-381
6. Oh J, Sahgal A, Sanghera P, Tsao MN, Davey P, Lam L, Symons S, Aviv R, Perry JR (2011) Gliobastoma: patterns of recurrence and efficacy of salvage treatments. Can J Neurol Sci 38:621-625
7. Mercier L, Del Maestro RF, Petrecca K, Kochanowska A, Drouin S, Yan CX, Janke AL, Chen SJ, Collins DL (2011) New prototype neuronavigation system based on preoperative imaging and intraoperative freehand ultrasound: system description and validation. Int J Comput Assist Radiol Surg 6:507-522
8. Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Van den Bent MJ, Change SM (2012) Application of novel response/progression measures for surgically delivered therapies for Gliomas: response assessment in neuro-oncology RANO (working group). Neurosurgery 70:234-244
9. Wen PY, Macdonal DR, Reardon DA, Cloughesy TF, Sorenson AG, Galanis E, DeFroot J, Wick W, Gilber MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, Van Den Bent MJ, Chang SM (2010) Updated response assessment criteria for high grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963-1972
10. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Oulad Ben Taib N, Rorive S, David P, Brotchi J, Levivier M (2006) Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 104:238-253
11. Pirotte BJM, Levivier M, Goldman S, Massager N, Wikler D, Dewitte O, Bruneau M, Rorive S, David P, Brotchi J (2009) Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery 64:471-481
12. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401
13. Stummer W, Novotny A, Stepp H, Goetz C, Bise K (2000) Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013
14. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncol 5:79-88
15. Pan E, Mitchell SB, Tsai JS (2008) A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. J Neurooncol 88:353-3577